Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Why should I use sharewise

How does sharewise work?


Sign up for free

Get yourself a free user account

Show more

Look for a stock/index

Choose a specific stock or index

Show more


Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard

Show more


Help us make sharewise better and help us in making it a success

Show more
sharewise ist auf Deutsch und Englisch verfügbar.
sharewise is available in German and English.

Top Buy/Sell

Security Price Target price
Wirecard AG €135.15 €165.50
Alibaba Group Holding Ltd ADR €202.00 €209.26 Inc. €1,959.0 €1,914.8
Security Price Target price
Vapiano €3.75 €2.00
Eco Atlantic Oil and Gas Ltd €0.39 €0.90
Nymox Pharmaceutical Corp. €2.94 €1.80

Tops & Flops

Security Price Change (%) (%)
Interpublic Group Of Companies Inc. €22.60 8.650%
Mohawk Industries Inc. ? 4.070%
CMS Energy Corp. €63.50 3.250%
Alexandria Real Estate Equ. €160.00 3.230%
Newell Rubbermaid €18.55 3.170%
Security Price Change (%) (%)
Leidos Holdings Inc. €99.00 -5.710%
MGM Resorts International €29.40 -5.160%
Applied Materials Inc. €59.41 -4.490%
Amerisourcebergen €87.50 -4.000%
Martin Marietta Materials €242.00 -3.940%

Top News

Most active discussions

I am working as a Marketing Executive at Agenter which is the best place for anyone who wants to....

Sell with target price 350.0

Buy with target price 10.0


Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia

Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral

Sensorion Receives Ethics Committee Approval to Include New Military Sites in SENS-401 Phase 2 study

Regulatory News:

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotech company which specializes in the development of novel therapies to restore, treat and prevent within the

Lysogene Reports its Cash Position as of 31 December 2019

Regulatory News:

Lysogene (Paris:LYS) (FR0013233475 – LYS), a pioneering Phase 3 biopharmaceutical company specializing in gene therapy targeting central nervous system (CNS) diseases, today

4 Reasons to Buy Alibaba Stock After Its Third-Quarter Earnings

Alibaba's (NYSE: BABA) stock dipped slightly after the Chinese tech giant posted its third-quarter earnings on Thursday. Its revenue rose 38% annually to 161.46 billion yuan ($23.19 billion)

Mannatech Declares Fourth Quarter 2019 Dividend

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend

EPR Properties Declares Monthly Dividend for Common Shareholders

EPR Properties (NYSE:EPR) today announced that its Board of Trustees has declared its monthly cash dividend to common shareholders. The dividend of $0.375 per common share is payable March 16, 2020

Annaly Capital Management, Inc. Announces Preferred Dividends

In accordance with the terms of Annaly’s 7.50% Series D Cumulative Redeemable Preferred Stock (“Series D Preferred Stock”), the Board has declared a Series D Preferred Stock cash dividend for the

Gap Inc. Updates Date for Fourth Quarter Fiscal 2019 Report

Gap Inc. (NYSE: GPS) will report its fourth quarter 2019 earnings results by press release on March 12, 2020 at 1:15 p.m. Pacific Time.

In addition, the company will host a summary of Gap Inc.’s


Compete in Catch the Monkey ...

... and win a prize!